Personalised patient support programme with emphasis on digital launched by Teva for MS patients
Pharma company, Teva, has launched a new patient support programme that offers personalised, flexible digital support to patients with relapsing forms of multiple sclerosis.
The firm says the MS Care Programme is the first of its kind to offer an “individually-based programme” in MS, combing “individualised digital tools” with real life guidance from a nurse support time and advice line.
Tailored to each patient and their treatment journey, the belief-based programme is based on a WHO framework that combines information, behavioural skills and motivation.
Marc van Kempen, VP Global Development, Patient Solutions at Teva, said: “Knowing that each reaction to a diagnosis of MS is unique, we took particular care to build a support programme that meets the diverse needs of all patients.
“With input from both patients and experts in MS, we’ve developed MS Care to provide support and guidance that can make a difference to patients and their families, as they navigate the challenges associated with MS, particularly in the weeks and months following diagnosis. We are excited about the launch of our advanced MS Care Programme and look forward to making it available in individual markets in the coming months.”
MS Care begins with a patient questionnaire, which explores the individual’s beliefs and attitudes to their condition and treatment, and from which a bespoke programme is created and optimises personalisation based on the patient’s answers.
Professor John Weinman, Professor of Psychology as Applied to Medicine at King’s College London, said: “Effective strategies to promote self-management and better support patient needs are essential. Studies have shown the benefits of patient support programmes to participants and their families. MS Care is unique in adapting its offering to meet the very specific individual needs of people with relapsing forms of MS, based on their individual beliefs and support needs.”
He added: “It’s very important not to underestimate the value of psychological support.”
Teva said the programme not only benefits patients and their families, but also the wider healthcare system in the form of cost savings by relieving pressure on other MS services, thereby reducing workload of MS nurses.